Pet Information > Others > Pet Articles > Pet Medications in the U.S.: Prescription and Over-the-Counter Remedies as Consumer Products

Pet Medications in the U.S.: Prescription and Over-the-Counter Remedies as Consumer Products

2016/5/3 15:13:22

Aarkstore.com announces, a new market research report is available in its vast collection:

Pet Medications in the U.S.: Prescription and Over-the-Counter Remedies as Consumer Products, 2nd Edition

http://www.aarkstore.com/reports/Pet-Medications-in-the-U-S-Prescription-and-Over-the-Counter-Remedies-as-Consumer-Products-2nd-Edition-157629.html

Seismic shifts are underway in the U.S. market for pet medications as the top veterinary brands of flea/tick spot-ons enter broader distribution; Bayer is leading the way with Advantage and K9 Advantix. At the same time, generic versions of fipronil (the active ingredient in Merial’s Frontline) are coming onto the scene, in some cases resulting in court battles and product withdrawals. Also upping the ante, major retailers including Walmart and Target are moving into the pet medications space both in store and online, representing new competition to veterinarians and third-party Internet retailers such as PetMed Express. The upshot is increased price pressure, but also potential for an expanded base of purchasers as pet specialty and mass-market retailers create stronger pet health departments centered around formerly vet-only products. Also bolstering market prospects, all of the world’s largest pharmaceutical companies continue to invest in medications for companion animals, often mirroring trends in human medications while targeting the needs of the growing populations of aging and overweight pets.

Bringing in broad perspective from other reports in Packaged Facts’ extensive Pet Market Collection, this report analyzes the market for prescription, over-the-counter, and “ethical” (nonprescription medications whose distribution is restricted by the manufacturer to veterinarians) medications for dogs and cats, with a particular focus on brand-name products used by consumers and on antiparasitics. Retail sales are quantified and projected forward through 2015, and broken out by product type, animal type and retail channel. Despite the lingering impact of the recession, the market outlook remains strong, with U.S. retail sales projected to grow 38% from 2010 to 2015 to reach $9.3 billion. The report provides in-depth coverage of competitive trends and new product trends, and features exclusive consumer data from Packaged Facts’ May-June 2011 Pet Owner Survey.
Uniquely cross-tabulated consumer survey results from Experian Simmons provide additional insight into pet medication consumer usage rates, demographics and psychographics.

Table of Contents :

hapter 1: Executive Summary

Scope and Methodology

Market Definition

Product Regulation

Report Methodology

Market Trends

Market Size & Composition

U.S. Retail Sales of Pet Medications at $6.7 Billion in 2011

Share of Sales by Distribution Channel

Figure 1-1: Share of U.S. Retail Sales of Pet Medications by Distribution Channel, 2011 (percent)

Market Outlook

Figure 1-2: Projected U.S. Retail Sales of Pet Medications: 2011-2015 (in billions of dollars)

For More Related Reports Please follow the link :

Private Label Credit Cards in the U.S., 7th Edition

Tea and Ready-to-Drink Tea in the U.S., 4th Edition

Convenience Store Foodservice Trends in the U.S.

Fats and Salad/Cooking Oils in the U.S.: Butter, Margarine, Olive Oil, and Beyond

The Latino Health and Beauty Care Shopper

From: Aarkstore Enterprise

Contact: Marketing Team

Mob.No.918149852585/919272852585

Email: enquiry@aarkstore.com

URL: http://www.aarkstore.com/

http://in.linkedin.com/in/aarkstore

http://www.facebook.com/aarkstore